Pain Research and Management / 2017 / Article / Tab 3

Review Article

Trigeminal Neuralgia, Glossopharyngeal Neuralgia, and Myofascial Pain Dysfunction Syndrome: An Update

Table 3

Characteristics and management of glossopharyngeal neuralgia in the maxillofacial region.

DiseasesClinical featuresPharmacological treatmentsSurgical /local treatmentsLimitation

Glossopharyngeal neuralgiaPain, dull type
Pain duration, short duration
Intensity, mild to moderate
Localization, diffuse
Characteristics, usually pain in the throat/ mouth floor
Trigger point, swallowing
CarbamazepineGN nerve block(i) Chance of trauma to the internal jugular vein and carotid artery
(ii) Hematoma formation
Gabapentin
pregabalin
Myotherapy
Percutaneous radiofrequency thermal rhizotomy
(i) Regular monitoring is not possible
(ii) Recurrence
(iii) Hoarseness of voice
(iv) Vocal cord paralysis, and dysphagia (difficulty in swallowing)
Injections(i) As it is a painful procedure, the patient feels uncomfortable during injection
Direct section of the nerve in the cerebellopontine angle(i) High morbidity with neurologic and life threatening condition
(ii) Thromboembolic complication
(iii) Meningitis
(iv) Cerebrospinal fluid leak,
(v) Cutaneous flap distension
(vi) Facial nerve dysfunction
(vii) Ocular dysfunction
(viii) Tinnitus
Sedatives
(on condition)
Microvascular decompression(i) Low recurrence of pain
(ii) Chance of nerve damage result
(iii) Hoarseness
(iv) Difficulty swallowing (dysphagia)
(v) Unsteady gait

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.